ENTEROSYS - Gut Is The Link
Biotechnology Research • 
Labège, Occitanie, France • 1-10 Employees
Company overview
| Headquarters | 57 rue de l'innovation, Labège, Occitanie 31670, FR |
| Phone number | +33673754526 |
| Website | |
| Keywords | Neurodegenerative Diseases, Type 2 Diabetes, Preclinical Studies, Dermatological Diseases, Metabolic Diseases, Gastrointestinal Diseases, Body Weight Control, Enteric Nervous System Targetting, Gut-Brain Axis, Gut-Organs Axis |
| Founded | 2017 |
| Employees | 1-10 |
Key Contact at ENTEROSYS - Gut Is The Link
Jean-Christophe Malrieu
Ceo
ENTEROSYS - Gut Is The Link Email Formats
ENTEROSYS - Gut Is The Link uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@enterosys.com), used 71.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@enterosys.com | 71.4% |
{first initial}.{last name} | j.doe@enterosys.com | 28.6% |
About ENTEROSYS - Gut Is The Link
🔬 About ENTEROSYS At ENTEROSYS, we are science enthusiasts 🧪 driven by a conviction deeply rooted in medical history: for over two millennia, it has been acknowledged that the key to understanding many diseases lies in our digestive system and its interactions with other organs. Based on this ancient wisdom, we have embraced a modern and holistic approach focused on digestive physiology and the communication between the gut and peripheral organs. Specializing in the preclinical evaluation of compounds with therapeutic potential 💊, we utilize cutting-edge techniques to analyze physiological parameters in real time. Our unique expertise enables the development of proof of concept and precise study of the mechanisms of action of molecules aimed at preventing risk factors or treating diseases, including neurodegenerative 🧠 and metabolic disorders. Key Figures: Over 7️⃣ years of experience in preclinical CRO (Contract Research Organization) services 🔬. Over 7️⃣5️⃣% of clients are satisfied with our services and commission one or more additional studies 🤝. Over 5️⃣0️⃣0️⃣ scientific publications produced by the company’s co-founders 📚. Our Services: Customized R&D projects 🗝️ to test therapeutic compounds. Innovative studies to differentiate in competitive markets 🚀. Revolutionary methods to speed up asset development 🛠️. A broad range of Unique Technologies: Accelerate the development of your assets with our revolutionary methods 🛠️. Diverse Testing: We provide a wide range of tests for the dermocosmetic 💄, nutraceutical 🌱, and pharmaceutical industries 🏥. Our Mission: To provide innovative preclinical solutions and advanced preclinical models to enhance and strategically position your molecules 💡. At ENTEROSYS, each client receives personalized support tailored to their specific needs 🎯.
ENTEROSYS - Gut Is The Link revenue & valuation
| Annual revenue | $2,700,000 |
| Revenue per employee | $450,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $8,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
ENTEROSYS - Gut Is The Link has 6 employees across 4 departments.
Departments
Number of employees
Funding Data
ENTEROSYS - Gut Is The Link has never raised funding before.
ENTEROSYS - Gut Is The Link Tech Stack
Discover the technologies and tools that power ENTEROSYS - Gut Is The Link's digital infrastructure, from frameworks to analytics platforms.
Hosting
Programming languages
United Kingdom
Singapore
United States
Spain
Canada
AustraliaFrequently asked questions
4.8
40,000 users
